Consequences of Genetically Engineered Milk
Eleven years ago, the greatest controversy in FDA history began with a lie when the Clinton White House (Executive Branch Report on rbGH, February 9, 1994) concluded: "BGH-treated milk is safe because it is indistinguishable from normal milk."
The drug manufacturer (Monsanto) hired ex-Surgeon General, C. Everett Koop to compound the lie. Koop's press release, dated February 6, 1994: "Milk from cows given supplemental bovine somatotropin is the same as any other milk...Unfortunately, a few fringe groups are using misleading statements and blatant falsehoods as part of a long-running campaign to scare consumers about a perfectly safe food."
Did the National Institutes of Health agree? Here is what they concluded four years earlier: "Recombinant rbGH treatment produces an increase in the concentration of insulin-like growth factor-I (IGF-I) in cow's milk." "Levels of IGF increase in milk after cows are treated with rbGH."
National Institutes of Health Assessment of Bovine Somatotropin, December, 1990: "A strong positive association was observed between IGF-I levels and prostate cancer risk." Science, vol. 279. January 23, 1998
"Insulin-like growth factor is thought to have a role in breast cancer." The Lancet, vol. 351. May 9, 1998
"High plasma levels of IGF-I were associated with an increased risk of lung cancer. Plasma levels of IGF-I are higher...in patients with lung cancer than in control subjects." Journal of the National Cancer Institute, vol. 91, no. 2. January 20, 1999.
"The insulin-like growth factor (IGF) system is widely involved in human carcinogenesis. A significant association between high circulating IGF-I concentrations and an increased risk of lung, colon, prostate and pre- menopausal breast cancer has recently been reported." International Journal of Cancer, 2000 Aug, 87:4, 601-5
"...serum IGF-I levels increased significantly in the milk drinking group, anincrease of about 10% above baseline-but was unchanged in the control group." Journal of the American Dietetic Association, vol. 99, no. 10. October 1999
Sent by: Robert Cohen http://www.notmilk.com
From ECOTERRA Intl.
The drug manufacturer (Monsanto) hired ex-Surgeon General, C. Everett Koop to compound the lie. Koop's press release, dated February 6, 1994: "Milk from cows given supplemental bovine somatotropin is the same as any other milk...Unfortunately, a few fringe groups are using misleading statements and blatant falsehoods as part of a long-running campaign to scare consumers about a perfectly safe food."
Did the National Institutes of Health agree? Here is what they concluded four years earlier: "Recombinant rbGH treatment produces an increase in the concentration of insulin-like growth factor-I (IGF-I) in cow's milk." "Levels of IGF increase in milk after cows are treated with rbGH."
National Institutes of Health Assessment of Bovine Somatotropin, December, 1990: "A strong positive association was observed between IGF-I levels and prostate cancer risk." Science, vol. 279. January 23, 1998
"Insulin-like growth factor is thought to have a role in breast cancer." The Lancet, vol. 351. May 9, 1998
"High plasma levels of IGF-I were associated with an increased risk of lung cancer. Plasma levels of IGF-I are higher...in patients with lung cancer than in control subjects." Journal of the National Cancer Institute, vol. 91, no. 2. January 20, 1999.
"The insulin-like growth factor (IGF) system is widely involved in human carcinogenesis. A significant association between high circulating IGF-I concentrations and an increased risk of lung, colon, prostate and pre- menopausal breast cancer has recently been reported." International Journal of Cancer, 2000 Aug, 87:4, 601-5
"...serum IGF-I levels increased significantly in the milk drinking group, anincrease of about 10% above baseline-but was unchanged in the control group." Journal of the American Dietetic Association, vol. 99, no. 10. October 1999
Sent by: Robert Cohen http://www.notmilk.com
From ECOTERRA Intl.
Starmail - 31. Jan, 14:42
